- Home
- DEVS vs AKTX Comparison
DEVS vs AKTX Comparison
Compare DEVS & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEVS
- AKTX
- Stock Information
- Founded
- DEVS N/A
- AKTX N/A
- Country
- DEVS
- AKTX United States
- Employees
- DEVS N/A
- AKTX N/A
- Industry
- DEVS
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- DEVS
- AKTX Health Care
- Exchange
- DEVS NYSE
- AKTX Nasdaq
- Market Cap
- DEVS 30.1M
- AKTX 29.5M
- IPO Year
- DEVS N/A
- AKTX N/A
- Fundamental
- Price
- DEVS $0.72
- AKTX $2.32
- Analyst Decision
- DEVS
- AKTX
- Analyst Count
- DEVS 0
- AKTX 0
- Target Price
- DEVS N/A
- AKTX N/A
- AVG Volume (30 Days)
- DEVS N/A
- AKTX 15.6K
- Earning Date
- DEVS N/A
- AKTX 11-26-2024
- Dividend Yield
- DEVS N/A
- AKTX N/A
- EPS Growth
- DEVS N/A
- AKTX N/A
- EPS
- DEVS N/A
- AKTX N/A
- Revenue
- DEVS N/A
- AKTX N/A
- Revenue This Year
- DEVS N/A
- AKTX N/A
- Revenue Next Year
- DEVS N/A
- AKTX N/A
- P/E Ratio
- DEVS N/A
- AKTX N/A
- Revenue Growth
- DEVS N/A
- AKTX N/A
- 52 Week Low
- DEVS N/A
- AKTX $1.08
- 52 Week High
- DEVS N/A
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- DEVS N/A
- AKTX 40.54
- Support Level
- DEVS N/A
- AKTX $1.77
- Resistance Level
- DEVS N/A
- AKTX $2.40
- Average True Range (ATR)
- DEVS 0.00
- AKTX 0.27
- MACD
- DEVS 0.00
- AKTX -0.00
- Stochastic Oscillator
- DEVS 0.00
- AKTX 31.16
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve their sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).